The Fortune 500 pharma giant will sequence the exomes of 10 million people, with the goal of developing new therapies and ...

Cutting-edge targeted therapies are pushing back the line between life and death for cancer patients.However, these ...

Patients of European ancestry are more likely to find a match to the latest targeted cancer drugs than patients of other ancestries, according to new MSK research. This trend could exacerbate ...

In 2016, ahead of the US presidential election, the National Academy of Medicine launched the strategic initiative Vital Directions for Health and Health Care—a series of papers on critical areas of ...

From medical devices to OTC drugs, preemption to expert preclusion, New York state and federal courts issued decisions in ...

What is new is the convergence of a shared populist spirit of elements of the MAGA movement on the right and todays’ self-styled progressives on the left. Together, they find common cause in the ...

Delivering his first address as a reinaugurated president, Donald Trump spoke directly to communities that had historically ...

President Donald Trump started his second administration with a blitz of policy actions to reorient the U.S. government.His ...

With the use of deep learning and advanced algorithms, generative AI can promote acceleration in the design and development ...

The global health landscape is constantly challenged by the emergence and re-emergence of viral pathogens. While significant ...

Last week, two of the biggest and oldest companies in the burgeoning AI drug discovery space announced a surprise merger. In a roughly 75-25 deal, Recursion Bio and Exscientia will (if the merger ...